Exelixis (EXEL) Shares Outstanding (Weighted Average) (2010 - 2026)

Exelixis (EXEL) recorded quarterly Shares Outstanding (Weighted Average) of $258.3 million in Q2 2026, down 4.87% quarter-over-quarter from $271.6 million in Q1 2026, and down 7.34% on a YoY basis from $278.8 million in Q2 2025.

Exelixis (EXEL) Shares Outstanding (Weighted Average) (2010 - 2026) Analysis & Trends

Exelixis' Shares Outstanding (Weighted Average) history runs 17 years deep, the most recent figure standing at $258.3 million for Q2 2026.

  • In Q2 2026, Shares Outstanding (Weighted Average) fell 7.34% year-over-year to $258.3 million; the TTM figure through Apr 2026 stood at $258.3 million (down 7.34% YoY), while the FY2026 annual figure was $271.6 million, down 6.37% from the prior year.
  • Shares Outstanding (Weighted Average) was $258.3 million for Q2 2026 at Exelixis, down from $271.6 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $324.4 million in Q1 2023 to a low of $258.3 million in Q2 2026.
  • Historically, Shares Outstanding (Weighted Average) has averaged $300.4 million across 5 years, with a median of $300.8 million in 2024.
  • The sharpest annual moves came in 2022 and 2024: Shares Outstanding (Weighted Average) advanced 2.5% in 2022, then decreased 9.18% in 2024.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $321.5 million in 2022, then retreated by 1.05% to $318.2 million in 2023, then slipped by 8.26% to $291.9 million in 2024, then declined by 6.37% to $273.3 million in 2025, then dropped by 5.47% to $258.3 million in 2026.
  • The last three Shares Outstanding (Weighted Average) figures came in at $258.3 million (Q2 2026), $271.6 million (Q1 2026), and $273.3 million (Q4 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - 185,491.37 Bn
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - 400.00 Bn
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - 4,489.46 Bn
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn 100.00 Bn
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - 118.76 Bn
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - 417.01 Bn
7 Psyence Biomedical 251.43 Bn 251.42 Bn - 68.88 Bn
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn 254.10 Mn
9 Abivax 94.37 Bn 94.37 Bn - 928.40 Mn
10 Exelixis 13.37 Bn 12.59 Bn 590.86 Mn 258.33 Mn

Historic Data

Download Data
DateValue
Apr 3, 2026 258.33 Mn
Jan 2, 2026 271.57 Mn
Oct 3, 2025 273.27 Mn
Jul 4, 2025 275.69 Mn
Apr 4, 2025 278.80 Mn
Jan 3, 2025 290.03 Mn
Sep 27, 2024 291.87 Mn
Jun 28, 2024 294.99 Mn
Mar 29, 2024 300.76 Mn
Dec 29, 2023 318.15 Mn
Sep 29, 2023 321.37 Mn
Jun 30, 2023 324.31 Mn
Mar 31, 2023 324.42 Mn
Dec 30, 2022 321.53 Mn
Sep 30, 2022 320.95 Mn
Jul 1, 2022 321.12 Mn
Apr 1, 2022 319.58 Mn
Dec 31, 2021 314.88 Mn
Oct 1, 2021 313.99 Mn
Jul 2, 2021 313.30 Mn